Skip to main content
. 2022 Jul 15;82:104173. doi: 10.1016/j.ebiom.2022.104173

Table 3.

dcRT-MLPA Gene signatures Good versus Poor obtained by pooling the study groups and the cohorts.

Diagnosis signature
Gene Module
GBP1 IFN signaling genes
FCGR1A IFN signaling genes
STAT1 IFN signaling genes
IFITM3 IFN signaling genes
BCL2 Apoptosis - Survival
CCL4 Treg associated genes
TLR9 Pattern recognition receptors
CD274 IFN signaling genes
Week two signature
Gene Module
GBP5 IFN signaling genes
INDO IFN signaling genes
GBP1 IFN signaling genes
BMP6 Cell growth - proliferation
CXCL9 Chemokines
GATA3 Th2 associated genes
FCGR1A IFN signaling genes
MMP9 Inflammation
PTPRCv1 T cell subset markers
SPP1 Inflammation
CD3E T cell subset markers
ASAP1 Small GTPases - (Rho) GTPase activating proteins
IL5 Th2 associated genes
TNFRSF1B Apoptosis - Survival
NLRP2 Inflammasome components
MRC1 Pattern recognition receptors
NLRP6 Inflammasome components
IL22RA1 Th17 associated genes
VEGF Cell growth - proliferation
KIF1B Intracellular transport
CCL19 Chemokines
CD209 Pattern recognition receptors
Month 2 Signature
Gene Module
BLR1 G protein-coupled receptors
BMP6 Cell growth - proliferation
CCL13 Chemokines
GBP1 IFN signaling genes
GBP2 IFN signaling genes
GBP5 IFN signaling genes
IFI16 IFN signaling genes
IL9 Th9 associated genes
INDO IFN signaling genes
MMP9 Inflammation
NOD2 Pattern recognition receptors
OAS3 IFN signaling genes
PTPRCv2 T cell subset markers
TAP1 IFN signaling genes

Genes that appeared in more than one gene signature (diagnosis, week two or month two) are shown in bold. Gene signatures were obtained by down-sampling the majority class (good TB treatment outcome).